Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), and Region - Global Forecast to 2030
The lateral flow assays market is estimated to grow from USD 8.51 billion in 2025 to USD 12.52 billion by 2030 at a CAGR of 8.0%, during the forecast period. This is due to the high prevalence of infectious diseases worldwide and the subsequent need for testing, rapid growth in the geriatric population, the rising use of home-based lateral flow assay devices, and the growing demand for POC testing, which are the major factors driving the growth of this market. However, inconsistent accuracy compared to other methods and the reluctance of doctors and patients to shift from traditional diagnostics restrain the growth of the lateral flow assays market.
“The clinical testing segment of the lateral flow assays market, by application, is estimated to hold the largest position during the forecast period.”
The clinical testing segment is the largest application segment in the lateral flow assays market. Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2024. This trend is projected to continue during the study period. The large share of this application segment can be attributed to the rising prevalence of chronic diseases and infectious diseases worldwide, the growing geriatric population, increasing patient awareness about rapid test options, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.
“The hospitals & clinics segment accounted for the largest market share in the lateral flow assays market.”
Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment accounted for the largest market share in 2024. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment.
“North America segment of the lateral flow assays market, by region, is estimated to account for the largest share during the forecast period.”
The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America holds the leading position in this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioM?rieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).
Research Coverage
This report studies the lateral flow assays market based on product, application, technique, sample type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following points:
“The clinical testing segment of the lateral flow assays market, by application, is estimated to hold the largest position during the forecast period.”
The clinical testing segment is the largest application segment in the lateral flow assays market. Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2024. This trend is projected to continue during the study period. The large share of this application segment can be attributed to the rising prevalence of chronic diseases and infectious diseases worldwide, the growing geriatric population, increasing patient awareness about rapid test options, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.
“The hospitals & clinics segment accounted for the largest market share in the lateral flow assays market.”
Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment accounted for the largest market share in 2024. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment.
“North America segment of the lateral flow assays market, by region, is estimated to account for the largest share during the forecast period.”
The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America holds the leading position in this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioM?rieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).
Research Coverage
This report studies the lateral flow assays market based on product, application, technique, sample type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following points:
- Analysis of key drivers (High prevalence of infectious diseases, Rising geriatric population, Growing use of home-based lateral flow assay devices, and Growing demand for POC testing), restraints (Inconsistent results of lateral flow assay tests), opportunities (Evolving applications of lateral flow assays and Rising demand for lateral flow assays in food & beverage industry), challenges (Limited reimbursements for lateral flow assay products and Difficulties in procuring quality raw materials to develop tests).
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lateral flow assays market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the lateral flow assays market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lateral flow assays market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Primary interviews
2.2.1.4 Approach 4: Growth Forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY-RELATED ASSUMPTIONS
2.4.2 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
4.2 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY
4.3 LATERAL FLOW ASSAYS MARKET, BY COUNTRY
4.4 LATERAL FLOW ASSAYS MARKET: REGIONAL MIX
4.5 LATERAL FLOW ASSAYS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
5.2.1.2 Rise in geriatric population
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growth in demand for POC testing
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assays
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
5.2.3.2 Rise in demand for lateral flow assays in food & beverage industry
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials to develop tests
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Immunochromatography
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Lyophilization (Freeze-drying) Technologies
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY LANDSCAPE
5.5.1 REGULATORY ANALYSIS
5.5.1.1 North America
5.5.1.2 Europe
5.5.1.3 Asia Pacific
5.5.1.3.1 India
5.5.1.3.2 China
5.5.1.3.3 Japan
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Asia Pacific
5.5.2.4 Latin America
5.5.2.5 Rest of the world
5.6 PATENT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 382200)
5.7.2 EXPORT DATA (HS CODE 382200)
5.8 PRICING ANALYSIS
5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND, BY REGION
5.9 KEY CONFERENCES AND EVENTS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 BUYING CRITERIA
5.11 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
5.12 VALUE CHAIN ANALYSIS
5.13 SUPPLY CHAIN ANALYSIS
5.14 IMPACT OF AI ON LATERAL FLOW ASSAYS MARKET
5.14.1 INTRODUCTION
5.14.2 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET
5.14.3 AI USE CASES
5.14.4 KEY COMPANIES IMPLEMENTING AI
5.14.5 FUTURE OF AI IN LATERAL FLOW ASSAYS MARKET
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 QUIDEL LAUNCHED NEW TEST WITH BROADER DETECTION WINDOW
5.16.2 ABINGTON OFFERED HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
5.16.3 SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
5.17 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.19 INVESTMENT AND FUNDING SCENARIO
5.20 IMPACT OF US TARIFF REGULATION ON LATERAL FLOW ASSAYS MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 KEY IMPACTS ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES
5.20.5.1 Hospitals and Clinics
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KITS & REAGENTS
6.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET
6.3 READERS
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological evolution and demand for accuracy to drive adoption
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive segment
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL TESTING
7.2.1 INFECTIOUS DISEASE TESTING
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market
7.2.1.2 Influenza
7.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays
7.2.1.3 Sexually transmitted infections
7.2.1.3.1 HIV
7.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market
7.2.1.3.2 HPV
7.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering broad range of genotypes, coupled with higher incidence of cervical cancer to drive segment
7.2.1.3.3 Chlamydia
7.2.1.3.3.1 Greater viability of advanced techniques to drive market
7.2.1.3.4 Gonorrhea
7.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth
7.2.1.3.5 Syphilis
7.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth
7.2.1.3.6 Other sexually transmitted infections
7.2.1.4 Hepatitis
7.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
7.2.1.5 Tuberculosis
7.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market
7.2.1.6 Other infectious diseases
7.2.2 CARDIAC MARKER TESTING
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
7.2.2.3 BNP & NT-proBNP
7.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
7.2.2.5 D-Dimer
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
7.2.2.6 Other cardiac marker testing
7.2.3 PREGNANCY & FERTILITY TESTING
7.2.3.1 Pregnancy testing
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
7.2.3.2 Fertility testing
7.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
7.2.6 OTHER CLINICAL TESTS
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
8.2 SANDWICH ASSAYS
8.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET
9 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE
9.1 INTRODUCTION
9.2 BLOOD SAMPLES
9.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
9.5 OTHER SAMPLES
10 LATERAL FLOW ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & CLINICS
10.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
10.4 DIAGNOSTIC LABORATORIES
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 INCREASE IN FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
10.6 OTHER END USERS
11 LATERAL FLOW ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Large patient base to drive market growth
11.2.3 CANADA
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Well-developed healthcare system and rise in geriatric population to fuel growth
11.3.3 UK
11.3.3.1 Growth in incidence of chronic conditions to propel market growth
11.3.4 FRANCE
11.3.4.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
11.3.5 ITALY
11.3.5.1 Growth in initiatives toward decentralization of medical services to support market growth
11.3.6 SPAIN
11.3.6.1 Aging population and strong healthcare infrastructure to drive market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Growing elderly population and well-developed healthcare system to drive market
11.4.3 CHINA
11.4.3.1 Modernized healthcare system to drive market
11.4.4 INDIA
11.4.4.1 Growth in healthcare concerns and rise in income levels to propel market growth, despite lack of reimbursement and insurance coverage for lateral flow assay products
11.4.5 AUSTRALIA
11.4.5.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth
11.4.6 SOUTH KOREA
11.4.6.1 Growth in healthcare infrastructure to drive market
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 High private healthcare expenditure and rise in geriatric population to drive market
11.5.3 MEXICO
11.5.3.1 Increase in demand for advanced medical equipment to drive market
11.5.4 ARGENTINA
11.5.4.1 Availability of health insurance to favor market growth
11.5.5 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.7 GCC COUNTRIES
11.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
12.3 REVENUE ANALYSIS, 2020-2024
12.4 MARKET SHARE ANALYSIS, 2024
12.5 COMPANY VALUATION AND FINANCIAL METRICS
12.6 BRAND/PRODUCT COMPARISON
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.7.5.1 Company footprint
12.7.5.2 Regional Footprint
12.7.5.3 Product Footprint
12.7.5.4 Technique Footprint
12.7.5.5 Application Footprint
12.7.5.6 Sample type Footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.8.1 PROGRESSIVE COMPANIES
12.8.2 RESPONSIVE COMPANIES
12.8.3 DYNAMIC COMPANIES
12.8.4 STARTING BLOCKS
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.8.5.1 Detailed list of key startup/SME players
12.8.5.2 Competitive benchmarking of key startups/SMEs
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 ABBOTT LABORATORIES
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches & approvals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 F. HOFFMANN-LA ROCHE LTD.
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 MnM view
13.1.2.3.1 Right to win
13.1.2.3.2 Strategic choices
13.1.2.3.3 Weaknesses and competitive threats
13.1.3 DANAHER CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses and competitive threats
13.1.4 QUIDELORTHOORTHO CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Deals
13.1.5 SIEMENS AG
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.6 BECTON, DICKINSON AND COMPANY
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 BIOM?RIEUX SA
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Deals
13.1.8 THERMO FISHER SCIENTIFIC INC.
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 REVVITY, INC.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 QIAGEN N.V.
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 MERCK KGAA
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Expansions
13.1.12 HOLOGIC, INC.
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 SURMODICS, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.1.14 ORASURE TECHNOLOGIES
13.1.14.1 Business overview
13.1.14.2 Products offered
13.2 OTHER PLAYERS
13.2.1 CHEMBIO DIAGNOSTICS INC.
13.2.2 DCN DIAGNOSTICS
13.2.3 POLYSCIENCES INC.
13.2.4 ABINGDON HEALTH
13.2.5 ORANOXIS INC.
13.2.6 AESKU.GROUP GMBH
13.2.7 BIO GROUP MEDICAL SYSTEM S.R.L
13.2.8 PHARMACT GMBH
13.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
13.2.10 BIOPANDA REAGENTS LTD
13.2.11 ARTRON LABORATORIES INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Primary interviews
2.2.1.4 Approach 4: Growth Forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY-RELATED ASSUMPTIONS
2.4.2 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
4.2 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY
4.3 LATERAL FLOW ASSAYS MARKET, BY COUNTRY
4.4 LATERAL FLOW ASSAYS MARKET: REGIONAL MIX
4.5 LATERAL FLOW ASSAYS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
5.2.1.2 Rise in geriatric population
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growth in demand for POC testing
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assays
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
5.2.3.2 Rise in demand for lateral flow assays in food & beverage industry
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials to develop tests
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Immunochromatography
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Lyophilization (Freeze-drying) Technologies
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY LANDSCAPE
5.5.1 REGULATORY ANALYSIS
5.5.1.1 North America
5.5.1.2 Europe
5.5.1.3 Asia Pacific
5.5.1.3.1 India
5.5.1.3.2 China
5.5.1.3.3 Japan
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Asia Pacific
5.5.2.4 Latin America
5.5.2.5 Rest of the world
5.6 PATENT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 382200)
5.7.2 EXPORT DATA (HS CODE 382200)
5.8 PRICING ANALYSIS
5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND, BY REGION
5.9 KEY CONFERENCES AND EVENTS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 BUYING CRITERIA
5.11 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
5.12 VALUE CHAIN ANALYSIS
5.13 SUPPLY CHAIN ANALYSIS
5.14 IMPACT OF AI ON LATERAL FLOW ASSAYS MARKET
5.14.1 INTRODUCTION
5.14.2 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET
5.14.3 AI USE CASES
5.14.4 KEY COMPANIES IMPLEMENTING AI
5.14.5 FUTURE OF AI IN LATERAL FLOW ASSAYS MARKET
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 QUIDEL LAUNCHED NEW TEST WITH BROADER DETECTION WINDOW
5.16.2 ABINGTON OFFERED HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
5.16.3 SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
5.17 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.19 INVESTMENT AND FUNDING SCENARIO
5.20 IMPACT OF US TARIFF REGULATION ON LATERAL FLOW ASSAYS MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 KEY IMPACTS ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES
5.20.5.1 Hospitals and Clinics
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KITS & REAGENTS
6.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET
6.3 READERS
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological evolution and demand for accuracy to drive adoption
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive segment
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL TESTING
7.2.1 INFECTIOUS DISEASE TESTING
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market
7.2.1.2 Influenza
7.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays
7.2.1.3 Sexually transmitted infections
7.2.1.3.1 HIV
7.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market
7.2.1.3.2 HPV
7.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering broad range of genotypes, coupled with higher incidence of cervical cancer to drive segment
7.2.1.3.3 Chlamydia
7.2.1.3.3.1 Greater viability of advanced techniques to drive market
7.2.1.3.4 Gonorrhea
7.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth
7.2.1.3.5 Syphilis
7.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth
7.2.1.3.6 Other sexually transmitted infections
7.2.1.4 Hepatitis
7.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
7.2.1.5 Tuberculosis
7.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market
7.2.1.6 Other infectious diseases
7.2.2 CARDIAC MARKER TESTING
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
7.2.2.3 BNP & NT-proBNP
7.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
7.2.2.5 D-Dimer
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
7.2.2.6 Other cardiac marker testing
7.2.3 PREGNANCY & FERTILITY TESTING
7.2.3.1 Pregnancy testing
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
7.2.3.2 Fertility testing
7.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
7.2.6 OTHER CLINICAL TESTS
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
8.2 SANDWICH ASSAYS
8.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET
9 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE
9.1 INTRODUCTION
9.2 BLOOD SAMPLES
9.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
9.5 OTHER SAMPLES
10 LATERAL FLOW ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & CLINICS
10.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
10.4 DIAGNOSTIC LABORATORIES
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 INCREASE IN FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
10.6 OTHER END USERS
11 LATERAL FLOW ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Large patient base to drive market growth
11.2.3 CANADA
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Well-developed healthcare system and rise in geriatric population to fuel growth
11.3.3 UK
11.3.3.1 Growth in incidence of chronic conditions to propel market growth
11.3.4 FRANCE
11.3.4.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
11.3.5 ITALY
11.3.5.1 Growth in initiatives toward decentralization of medical services to support market growth
11.3.6 SPAIN
11.3.6.1 Aging population and strong healthcare infrastructure to drive market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Growing elderly population and well-developed healthcare system to drive market
11.4.3 CHINA
11.4.3.1 Modernized healthcare system to drive market
11.4.4 INDIA
11.4.4.1 Growth in healthcare concerns and rise in income levels to propel market growth, despite lack of reimbursement and insurance coverage for lateral flow assay products
11.4.5 AUSTRALIA
11.4.5.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth
11.4.6 SOUTH KOREA
11.4.6.1 Growth in healthcare infrastructure to drive market
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 High private healthcare expenditure and rise in geriatric population to drive market
11.5.3 MEXICO
11.5.3.1 Increase in demand for advanced medical equipment to drive market
11.5.4 ARGENTINA
11.5.4.1 Availability of health insurance to favor market growth
11.5.5 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.7 GCC COUNTRIES
11.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
12.3 REVENUE ANALYSIS, 2020-2024
12.4 MARKET SHARE ANALYSIS, 2024
12.5 COMPANY VALUATION AND FINANCIAL METRICS
12.6 BRAND/PRODUCT COMPARISON
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.7.5.1 Company footprint
12.7.5.2 Regional Footprint
12.7.5.3 Product Footprint
12.7.5.4 Technique Footprint
12.7.5.5 Application Footprint
12.7.5.6 Sample type Footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.8.1 PROGRESSIVE COMPANIES
12.8.2 RESPONSIVE COMPANIES
12.8.3 DYNAMIC COMPANIES
12.8.4 STARTING BLOCKS
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.8.5.1 Detailed list of key startup/SME players
12.8.5.2 Competitive benchmarking of key startups/SMEs
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 ABBOTT LABORATORIES
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches & approvals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 F. HOFFMANN-LA ROCHE LTD.
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 MnM view
13.1.2.3.1 Right to win
13.1.2.3.2 Strategic choices
13.1.2.3.3 Weaknesses and competitive threats
13.1.3 DANAHER CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses and competitive threats
13.1.4 QUIDELORTHOORTHO CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Deals
13.1.5 SIEMENS AG
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.6 BECTON, DICKINSON AND COMPANY
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 BIOM?RIEUX SA
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Deals
13.1.8 THERMO FISHER SCIENTIFIC INC.
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 REVVITY, INC.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 QIAGEN N.V.
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 MERCK KGAA
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Expansions
13.1.12 HOLOGIC, INC.
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 SURMODICS, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.1.14 ORASURE TECHNOLOGIES
13.1.14.1 Business overview
13.1.14.2 Products offered
13.2 OTHER PLAYERS
13.2.1 CHEMBIO DIAGNOSTICS INC.
13.2.2 DCN DIAGNOSTICS
13.2.3 POLYSCIENCES INC.
13.2.4 ABINGDON HEALTH
13.2.5 ORANOXIS INC.
13.2.6 AESKU.GROUP GMBH
13.2.7 BIO GROUP MEDICAL SYSTEM S.R.L
13.2.8 PHARMACT GMBH
13.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
13.2.10 BIOPANDA REAGENTS LTD
13.2.11 ARTRON LABORATORIES INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 KEY DATA FROM PRIMARY SOURCES
TABLE 3 LATERAL FLOW ASSAYS MARKET: RISK ASSESSMENT
TABLE 4 REAL INCIDENCE OF HIV, 2023 (MILLION PEOPLE)
TABLE 5 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
TABLE 6 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATERAL FLOW ASSAYS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025
TABLE 14 IMPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 15 EXPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 16 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY, 2023–2025 (USD)
TABLE 17 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY APPLICATION, 2023–2025 (USD)
TABLE 18 INDICATIVE AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2023 VS. 2024
TABLE 19 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, JUNE 2025–DECEMBER 2026
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 21 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 22 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
TABLE 23 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 25 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 26 LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 27 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28 EUROPE: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
TABLE 32 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 33 LATERAL FLOW ASSAYS MARKET, FOR READERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 EUROPE: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 52 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 58 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 MAJOR PRODUCTS: DENGUE TESTING
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 64 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2023–2030 (USD MILLION)
TABLE 69 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2023–2030 (USD MILLION)
TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2023–2030 (USD MILLION)
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 90 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2023–2030 (USD MILLION)
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2023–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 111 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2023–2030 (MILLION)
TABLE 116 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 126 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 128 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 133 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 138 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 143 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 164 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 169 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 175 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 176 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 177 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 180 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 181 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 182 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 184 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 185 LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 186 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 190 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 191 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 192 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 193 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 195 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 196 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 197 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 198 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 199 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 200 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 210 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 211 LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 212 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 213 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 215 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216 LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 217 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 218 EUROPE: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 219 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 220 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 221 LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 222 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 223 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 224 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 225 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 227 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 228 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 229 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 230 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 231 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 232 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 233 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 234 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 236 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 237 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 238 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 239 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 240 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 241 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 242 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 243 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 244 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 245 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 246 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 247 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 248 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 249 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 250 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 251 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 252 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 253 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION)
TABLE 254 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 256 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 257 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 258 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 259 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 260 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 261 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 263 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 264 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 265 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 266 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 268 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 269 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 270 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 271 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 273 LATERAL FLOW ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 274 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 275 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 276 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 277 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 287 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 288 US: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 290 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 292 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 297 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 298 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 299 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 309 EUROPE: MACROECONOMIC INDICATORS
TABLE 310 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 311 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 312 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 320 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 321 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 322 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLIO
TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 KEY DATA FROM PRIMARY SOURCES
TABLE 3 LATERAL FLOW ASSAYS MARKET: RISK ASSESSMENT
TABLE 4 REAL INCIDENCE OF HIV, 2023 (MILLION PEOPLE)
TABLE 5 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
TABLE 6 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATERAL FLOW ASSAYS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025
TABLE 14 IMPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 15 EXPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 16 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY, 2023–2025 (USD)
TABLE 17 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY APPLICATION, 2023–2025 (USD)
TABLE 18 INDICATIVE AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2023 VS. 2024
TABLE 19 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, JUNE 2025–DECEMBER 2026
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 21 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 22 UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET
TABLE 23 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 25 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 26 LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 27 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28 EUROPE: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
TABLE 32 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 33 LATERAL FLOW ASSAYS MARKET, FOR READERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 EUROPE: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 52 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 58 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 MAJOR PRODUCTS: DENGUE TESTING
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 64 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2023–2030 (USD MILLION)
TABLE 69 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2023–2030 (USD MILLION)
TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2023–2030 (USD MILLION)
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 90 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2023–2030 (USD MILLION)
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2023–2030 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 111 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2023–2030 (MILLION)
TABLE 116 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 126 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 128 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 133 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 138 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 143 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 164 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 169 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 175 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 176 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 177 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 180 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 181 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 182 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 184 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 185 LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 186 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 190 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 191 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 192 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 193 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 195 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 196 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 197 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 198 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 199 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 200 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2023–2030 (USD MILLION)
TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 210 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 211 LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 212 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 213 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 215 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216 LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 217 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 218 EUROPE: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 219 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 220 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 221 LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 222 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 223 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 224 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 225 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 227 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 228 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 229 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 230 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 231 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 232 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 233 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 234 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 235 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 236 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 237 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 238 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 239 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 240 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 241 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 242 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 243 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 244 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 245 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 246 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 247 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 248 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 249 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 250 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 251 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 252 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 253 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION)
TABLE 254 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 256 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 257 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 258 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 259 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 260 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 261 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 263 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 264 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 265 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 266 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 268 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 269 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 270 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 271 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 273 LATERAL FLOW ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 274 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 275 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 276 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 277 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 287 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 288 US: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 290 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 292 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 297 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 298 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 299 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 309 EUROPE: MACROECONOMIC INDICATORS
TABLE 310 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 311 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 312 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 320 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)
TABLE 321 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 322 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLIO
LIST OF FIGURES
FIGURE 1 LATERAL FLOW ASSAYS: MARKET SEGMENTATION
FIGURE 2 STUDY YEARS CONSIDERED
FIGURE 3 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN
FIGURE 4 KEY DATA FROM SECONDARY SOURCES
FIGURE 5 LIST OF PRIMARY SOURCES
FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION)
FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 15 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
FIGURE 16 LATERAL FLOW ASSAY MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF LATERAL FLOW ASSAYS MARKET
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
FIGURE 20 CLINICAL TESTING APPLICATION AND CHINA LED ASIA PACIFIC MARKET IN 2024
FIGURE 21 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
FIGURE 22 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 LATERAL FLOW ASSAYS MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
FIGURE 28 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
FIGURE 29 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 30 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 31 AI USE CASES
FIGURE 32 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
FIGURE 34 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024
FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2020–2024
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2024
FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 42 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT, 2024
FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2024
FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2024
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 49 QUIDELORTHOORTHO CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 50 SIEMENS AG: COMPANY SNAPSHOT, 2024
FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2024
FIGURE 52 BIOM?RIEUX SA: COMPANY SNAPSHOT, 2024
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT, 2024
FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT, 2024
FIGURE 55 QIAGEN N.V.: COMPANY SNAPSHOT, 2024
FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT, 2024
FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT, 2024
FIGURE 58 SURMODICS, INC.: COMPANY SNAPSHOT, 2024
FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT, 2024
FIGURE 1 LATERAL FLOW ASSAYS: MARKET SEGMENTATION
FIGURE 2 STUDY YEARS CONSIDERED
FIGURE 3 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN
FIGURE 4 KEY DATA FROM SECONDARY SOURCES
FIGURE 5 LIST OF PRIMARY SOURCES
FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION)
FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 15 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
FIGURE 16 LATERAL FLOW ASSAY MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF LATERAL FLOW ASSAYS MARKET
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
FIGURE 20 CLINICAL TESTING APPLICATION AND CHINA LED ASIA PACIFIC MARKET IN 2024
FIGURE 21 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
FIGURE 22 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 LATERAL FLOW ASSAYS MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
FIGURE 28 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
FIGURE 29 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 30 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 31 AI USE CASES
FIGURE 32 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET
FIGURE 34 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024
FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2020–2024
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2024
FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 42 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT, 2024
FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2024
FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2024
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 49 QUIDELORTHOORTHO CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 50 SIEMENS AG: COMPANY SNAPSHOT, 2024
FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2024
FIGURE 52 BIOM?RIEUX SA: COMPANY SNAPSHOT, 2024
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT, 2024
FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT, 2024
FIGURE 55 QIAGEN N.V.: COMPANY SNAPSHOT, 2024
FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT, 2024
FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT, 2024
FIGURE 58 SURMODICS, INC.: COMPANY SNAPSHOT, 2024
FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT, 2024
